EAMAS - Associazione Europea amici della Sindrome di McCune-Albright

European Association Friends of Mc Cune Albright Syndrome

Scegli la lingua:
IT EN FR DE ES

Contatta EAMAS


Home

Che cos'è EAMAS
Patologie trattate
Esperienze personali
Medici e ospedali
Glossario
Pubblicazioni
Link utili
Novità dell'associazione
Conferenze e simposi
Come finanziare EAMAS

Sponsor dell'anno

Ultimo aggiornamento:
24/09/2023

Best view 1024 x 768
Ottimizzato per IE



 

 

Pubblicazioni

Elenco completo

Elenco completo

PATOLOGIA: LINGUA:  
ARGOMENTO: TESTO:
TITOLOAUTORIEDITOREANNODOSSIERPAGINELINGUA
Increased proliferation of osteoblastic cells expressing the activating Gsa mutation in monostotic and polyostotic fibrous dysplasiaMarie PJ, de Pollak C, Chanson P, Lomri A,Am J Pathol19971501059-1069en
Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formationRiminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Robey PG,Am J Pathol19971511587-1600en
Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophyRingel MD, Schwindinger WF, Levine MA,Medicine (Baltimore)199675171-184en
Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patientsYang I, Park S, Ryu M, Woo J, Kim J, Kim Y , Choi Y,Eur J Endocrinol1996134720-726en
Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6 year old boy with McCune-Albright syndromeDotsch J, Kiess W, Hanze J, Repp R, Ludecke D, Blum WF, Rascher W,J Clin Endocrinol Metab1996813839-3842en
Functional and clinical consequences of mutations in the FSH receptorGromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E,Mol Cell Endocrinol1996125177-182en
Monthly urinary gonadotropin and ovarian hormone execretory patterns in normal girls and female patients with idiopathic precocious pubertyMaesaka H, Tachibana K, Adachi M, Okada T,Pediatr Res199640853-860en
Growth hormone-secreting pituitary adenoma associated with multiple bone cysts, skin pigmentation and aortitis syndromeIhara C, Shimatsu H, Murabe K, Kataoka C, Kondo, Nakao K,J Endocrinol Invest199619753-757en
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronateIllidge TM, Hussey M, Godden CW,Clin Oncol19968257-258en
Bisphosphonates: an efficient way to ontrol bone resorption in growing children. Studies in fibrous dyspalsia of bone. In: Schoenau E, ed. Paediatric Osteology: New Developments in Diagnostics and TherapyGlorieux FH, ,Amsterdam: Elsevier1996275-277en
Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndromeYamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S,J Clin Invest19969830-35en
Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: cyclical evidence for altered renal adenylate cyclase activityZung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA,Journal of Pediatric Endocrinology & Metabolism (JPEM)1995803576-3581en
Hypercalemia in a child with Ewing's sarcoma and bisphosphonate therapySevinir BB, Akyuz C, Kotiloglu E, Hazar V, Buyjkpamukcu M,Turk J Cancer19952591-94en
An activating Gsa mutation in present in fibrous dyspalsia of bone in the McCune-Albright syndromeShenker A, Weinstein LS, Sweet DE, Spiegel AM,J Clin Endocrinol Metab199479750-755en
An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesionMalchoff CD, Reardon G, MacGillivary DC, Yanase H, Rogol AD, Malchoff DM,J Clin Endocrinol Metab199478803-806en
McCune-Albright syndrome and acromegaly: clinical studies and response to treatment in five casesChanson P, Dib A, Visot A, Derome PJ,Eur J Endocrinol1994131229-234en
Severe immobilization-induced hypercalcaemia in a child after liver transplantation successufully treated with pamidronateProfumo RJ, Reese JC, Foy TM, Garibaldi LR, Kane RE,Transplantation199457301-303en
Aminohydroxypropylidene-bisphosphonate in the treatment of bone lesions in a case of Gaucher's disease type 3Bembi B, Agosti E, Boehm P, Nassimbeni G, Zanatta M, Vidoni L,Acta Paediatr Scand199483122-124en
Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestaions of Gaucher's dieseaseSamuel R, Katz K, Papapoulos SE, Yosipovitch Z, Zaizov R, Liberman U,Pediatrics199494385-389en
Bisphosphonates: pharmacology and effects on the growing skeletonPapapoulos SE,Acta Universitatis Carolinae Medica19944029-32en

Righe 20 di 186
Pagine: [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [  6  ] [ 7 ] [ 8 ] [ 9 ] [ 10 ] 

 


Login:
Password:


Non hai una password?
REGISTRATI

Scordato la password?
Perchè iscriversi?
Consigli di utilizzo


Contatta EAMAS
Associarsi ad EAMAS
Contatta il web master


EAMAS - Associazione Europea amici della Sindrome di McCune-Albright
Via Borgovecchio, 25 - 10041 Carignano (TO) - Italy - Tel:+39 011-9697258 - Fax:+39 011-9697258